PHAT vs GILD: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Gilead Sciences Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
$12.61
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | PHAT | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.02B | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.9% | 0.0% | PHAT |
| Gross Margin | 87.1% | 78.8% | PHAT |
Analyze PHAT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or GILD a better investment?
Comparing PHAT and GILD: Phathom Pharmaceuticals Inc has a market cap of $1.02B while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and GILD?
PHAT (Phathom Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or GILD?
PHAT has higher revenue growth at 0.9% vs 0.0% for GILD.
Which company is more profitable: PHAT or GILD?
Phathom Pharmaceuticals Inc (PHAT) has higher gross margins at 87.1% compared to 78.8% for GILD.
Which is the larger company: PHAT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $1.02B for PHAT.
Should I buy PHAT or GILD in 2026?
Both PHAT and GILD have investment merit. PHAT trades at $12.61 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and GILD stock?
Key differences: Market Cap ($1.02B vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.9% vs 0.0%), Gross Margin (87.1% vs 78.8%).